Csenge Advisory Group Buys 235 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Csenge Advisory Group increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,910 shares of the company’s stock after acquiring an additional 235 shares during the quarter. Csenge Advisory Group’s holdings in HCA Healthcare were worth $1,304,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Morgan Stanley increased its holdings in HCA Healthcare by 1.4% in the 3rd quarter. Morgan Stanley now owns 2,150,009 shares of the company’s stock valued at $528,860,000 after buying an additional 30,072 shares during the period. Creative Planning grew its holdings in shares of HCA Healthcare by 25.4% in the 3rd quarter. Creative Planning now owns 36,273 shares of the company’s stock worth $8,922,000 after purchasing an additional 7,350 shares during the last quarter. Comerica Bank grew its holdings in shares of HCA Healthcare by 623.3% in the 3rd quarter. Comerica Bank now owns 43,502 shares of the company’s stock worth $10,701,000 after purchasing an additional 37,488 shares during the last quarter. Public Sector Pension Investment Board grew its holdings in shares of HCA Healthcare by 9.1% in the 3rd quarter. Public Sector Pension Investment Board now owns 21,560 shares of the company’s stock worth $5,303,000 after purchasing an additional 1,804 shares during the last quarter. Finally, EP Wealth Advisors LLC grew its holdings in shares of HCA Healthcare by 501.8% in the 3rd quarter. EP Wealth Advisors LLC now owns 208,965 shares of the company’s stock worth $51,401,000 after purchasing an additional 174,240 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on HCA shares. Baird R W upgraded shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Cantor Fitzgerald restated an “overweight” rating and set a $335.00 target price on shares of HCA Healthcare in a research report on Tuesday. Robert W. Baird initiated coverage on shares of HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 target price on the stock. Finally, Barclays upped their target price on shares of HCA Healthcare from $367.00 to $376.00 and gave the company an “overweight” rating in a research report on Wednesday. Four investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $327.06.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jeffrey E. Cohen sold 1,650 shares of HCA Healthcare stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $313.00, for a total transaction of $516,450.00. Following the completion of the transaction, the senior vice president now directly owns 5,185 shares of the company’s stock, valued at $1,622,905. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, SVP Kathryn A. Torres sold 973 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the transaction, the senior vice president now owns 22,365 shares of the company’s stock, valued at $6,977,880. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Jeffrey E. Cohen sold 1,650 shares of the business’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $313.00, for a total value of $516,450.00. Following the completion of the transaction, the senior vice president now directly owns 5,185 shares of the company’s stock, valued at approximately $1,622,905. The disclosure for this sale can be found here. Insiders sold 12,397 shares of company stock valued at $3,921,929 in the last quarter. 1.70% of the stock is currently owned by insiders.

HCA Healthcare Stock Up 1.0 %

Shares of HCA traded up $3.29 during mid-day trading on Thursday, hitting $318.64. 890,436 shares of the company’s stock were exchanged, compared to its average volume of 1,104,986. The company has a market cap of $83.46 billion, a PE ratio of 15.72, a P/E/G ratio of 1.43 and a beta of 1.68. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $344.20. The company has a 50-day simple moving average of $327.08 and a 200 day simple moving average of $319.68. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 26th. The company reported $5.36 EPS for the quarter, beating the consensus estimate of $5.01 by $0.35. The company had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The firm’s revenue for the quarter was up 11.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $4.93 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 20.97 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Friday, June 14th were issued a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.83%. The ex-dividend date was Friday, June 14th. HCA Healthcare’s payout ratio is presently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.